Freedom Investment Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-1,408
| Closed | -$205K | – | 782 |
|
2024
Q3 | $205K | Sell |
1,408
-1,720
| -55% | -$250K | 0.02% | 713 |
|
2024
Q2 | $429K | Sell |
3,128
-5,489
| -64% | -$753K | 0.04% | 476 |
|
2024
Q1 | $1.18M | Sell |
8,617
-2,055
| -19% | -$282K | 0.09% | 209 |
|
2023
Q4 | $1.45M | Buy |
10,672
+1,011
| +10% | +$137K | 0.12% | 161 |
|
2023
Q3 | $1.18M | Sell |
9,661
-3,324
| -26% | -$407K | 0.14% | 168 |
|
2023
Q2 | $1.65M | Buy |
12,985
+9,040
| +229% | +$1.15M | 0.18% | 123 |
|
2023
Q1 | $510K | Sell |
3,945
-6,469
| -62% | -$836K | 0.06% | 400 |
|
2022
Q4 | $1.37M | Sell |
10,414
-644
| -6% | -$84.6K | 0.15% | 174 |
|
2022
Q3 | $1.29M | Sell |
11,058
-10,717
| -49% | -$1.25M | 0.15% | 174 |
|
2022
Q2 | $2.56M | Buy |
21,775
+9,477
| +77% | +$1.11M | 0.27% | 86 |
|
2022
Q1 | $1.6M | Buy |
+12,298
| New | +$1.6M | 0.14% | 186 |
|
2020
Q4 | – | Sell |
-23,369
| Closed | -$3.16M | – | 635 |
|
2020
Q3 | $3.16M | Buy |
+23,369
| New | +$3.16M | 0.34% | 59 |
|
2017
Q4 | – | Sell |
-5,052
| Closed | -$562K | – | 1149 |
|
2017
Q3 | $562K | Buy |
+5,052
| New | +$562K | 0.03% | 537 |
|
2015
Q4 | – | Sell |
-48,936
| Closed | -$218K | – | 787 |
|
2015
Q3 | $218K | Buy |
48,936
+45,573
| +1,355% | +$203K | 0.02% | 587 |
|
2015
Q2 | $414K | Buy |
+3,363
| New | +$414K | 0.04% | 400 |
|